Jan 8
|
Alphabet's Isomorphic Labs In Drug Discovery Deals With Eli Lilly, Novartis
|
Jan 8
|
UPDATE 2-Lilly CEO says weight-loss drug Zepbound weekly prescriptions hit 25,000 in December
|
Jan 8
|
Lilly CEO says weight-loss drug Zepbound weekly prescriptions hit 25,000 in December
|
Jan 8
|
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
|
Jan 8
|
Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep on inventing new things'
|
Jan 8
|
Eli Lilly CEO talks expanding innovation past obesity drugs
|
Jan 8
|
Dow Jones Futures Fall As Boeing Plunges On 737 Max Woes; Can Market Rally Hold Key Levels?
|
Jan 8
|
5 questions facing emerging biotech in 2024
|
Jan 7
|
Isomorphic inks deals with Eli Lilly and Novartis for drug discovery
|
Jan 6
|
2 Top Healthcare Stocks to Buy Right Now
|
Jan 5
|
11 Stocks Are Taking Off Already — And The Year Just Started
|
Jan 5
|
Novo Nordisk, IBD Stock Of The Day, Flashes Buy Signal Amid The Weight-Loss Craze
|
Jan 5
|
How weight loss drug costs could impact providers, taxpayers
|
Jan 5
|
Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk
|
Jan 5
|
Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review
|
Jan 5
|
NVS or LLY: Which Is the Better Value Stock Right Now?
|
Jan 5
|
Lilly (LLY) Starts Website to Help Access Tirzepatide Drugs
|
Jan 5
|
Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
|
Jan 5
|
Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals
|
Jan 5
|
Why WW International Stock Was Sinking Fast This Week
|